AAAAAA

   
Results: 1-10 |
Results: 10
THE OXIDATION OF DOPAMINE AND EPININE BY THE 2 FORMS OF MONOAMINE-OXIDASE FROM RAT-LIVER
Authors: BENEDETTI MS SANSON G BONA L GALLINA M PERSIANI S TIPTON KF
Citation: Ms. Benedetti et al., THE OXIDATION OF DOPAMINE AND EPININE BY THE 2 FORMS OF MONOAMINE-OXIDASE FROM RAT-LIVER, Journal of neural transmission. Supplementum, (52), 1998, pp. 233-238
PRELIMINARY PHARMACOKINETIC STUDY OF IBUPROFEN ENANTIOMERS AFTER ADMINISTRATION OF A NEW ORAL FORMULATION (IBUPROFEN ARGININE) TO HEALTHY MALE-VOLUNTEERS
Authors: FORNASINI G MONTI N BROGIN G GALLINA M EANDI M PERSIANI S BANI M DELLAPEPA C ZARA G BENEDETTI MS
Citation: G. Fornasini et al., PRELIMINARY PHARMACOKINETIC STUDY OF IBUPROFEN ENANTIOMERS AFTER ADMINISTRATION OF A NEW ORAL FORMULATION (IBUPROFEN ARGININE) TO HEALTHY MALE-VOLUNTEERS, Chirality, 9(3), 1997, pp. 297-302
CLINICAL AND PHARMACOKINETIC EVALUATION OF L-DOPA AND CABERGOLINE COTREATMENT IN PARKINSONS-DISEASE
Authors: DELDOTTO P COLZI A MUSATTI E BENEDETTI MS PERSIANI S FARIELLO R BONUCCELLI U
Citation: P. Deldotto et al., CLINICAL AND PHARMACOKINETIC EVALUATION OF L-DOPA AND CABERGOLINE COTREATMENT IN PARKINSONS-DISEASE, Clinical neuropharmacology, 20(5), 1997, pp. 455-465
DETERMINATION OF THE NEW AROMATASE INHIBITOR EXEMESTANE IN BIOLOGICAL-FLUIDS BY AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOLLOWED BY RADIOIMMUNOASSAY
Authors: PERSIANI S BROUTIN F CICIONI P BENEDETTI MS
Citation: S. Persiani et al., DETERMINATION OF THE NEW AROMATASE INHIBITOR EXEMESTANE IN BIOLOGICAL-FLUIDS BY AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOLLOWED BY RADIOIMMUNOASSAY, European journal of pharmaceutical sciences, 4(6), 1996, pp. 331-340
THE EFFECT OF FOOD ON CABERGOLINE PHARMACOKINETICS AND TOLERABILITY IN HEALTHY-VOLUNTEERS
Authors: PERSIANI S ROCCHETTI M PACCIARINI MA HOLT B TOON S STROLINBENEDETTI M
Citation: S. Persiani et al., THE EFFECT OF FOOD ON CABERGOLINE PHARMACOKINETICS AND TOLERABILITY IN HEALTHY-VOLUNTEERS, Biopharmaceutics & drug disposition, 17(5), 1996, pp. 443-455
PHARMACOKINETICS OF REPEATED LOW-DOSES OF EXEMESTANE (1, 2.5, 5, AND 10 MG) IN POSTMENOPAUSAL HEALTHY-VOLUNTEERS
Authors: PERSIANI S POGGESI I CICIONI P BENEDETTI MS
Citation: S. Persiani et al., PHARMACOKINETICS OF REPEATED LOW-DOSES OF EXEMESTANE (1, 2.5, 5, AND 10 MG) IN POSTMENOPAUSAL HEALTHY-VOLUNTEERS, European journal of cancer, 31A, 1995, pp. 952-952
LACK OF PHARMACOKINETIC INTERACTION BETWEEN THE SELECTIVE DOPAMINE AGONIST CABERGOLINE AND THE MAO-B INHIBITOR SELEGILINE
Authors: DOSTERT P BENEDETTI MS PERSIANI S LACROIX R BOSC M FIORENTINI F DEFFOND D VERNAY D DORDAIN G
Citation: P. Dostert et al., LACK OF PHARMACOKINETIC INTERACTION BETWEEN THE SELECTIVE DOPAMINE AGONIST CABERGOLINE AND THE MAO-B INHIBITOR SELEGILINE, Journal of neural transmission. Supplementum, (45), 1995, pp. 247-257
PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF CABERGOLINE, A PROLACTIN-LOWERING DRUG, AFTER ADMINISTRATION OF INCREASING ORAL DOSES (0.5, 1.0, AND 1.5 MILLIGRAMS) IN HEALTHY MALE-VOLUNTEERS
Authors: ANDREOTTI AC PIANEZZOLA E PERSIANI S PACCIARINI MA BENEDETTI MS PONTIROLI AE
Citation: Ac. Andreotti et al., PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF CABERGOLINE, A PROLACTIN-LOWERING DRUG, AFTER ADMINISTRATION OF INCREASING ORAL DOSES (0.5, 1.0, AND 1.5 MILLIGRAMS) IN HEALTHY MALE-VOLUNTEERS, The Journal of clinical endocrinology and metabolism, 80(3), 1995, pp. 841-845
RADIOIMMUNOASSAY FOR THE TESTOSTERONE 5-ALPHA-REDUCTASE INHIBITOR TUROSTERIDE IN BIOLOGICAL-FLUIDS
Authors: PERSIANI S BROUTIN F PIANEZZOLA E PANZERI A FONTE G FONTANA E BENEDETTI MS
Citation: S. Persiani et al., RADIOIMMUNOASSAY FOR THE TESTOSTERONE 5-ALPHA-REDUCTASE INHIBITOR TUROSTERIDE IN BIOLOGICAL-FLUIDS, Journal of immunoassay, 15(2), 1994, pp. 97-113
PHARMACODYNAMICS AND RELATIVE BIOAVAILABILITY OF CABERGOLINE TABLETS VS SOLUTION IN HEALTHY-VOLUNTEERS
Authors: PERSIANI S SASSOLAS G PISCITELLI G BIZOLLON CA POGGESI I PIANEZZOLA E EDWARDS DMF BENEDETTI MS
Citation: S. Persiani et al., PHARMACODYNAMICS AND RELATIVE BIOAVAILABILITY OF CABERGOLINE TABLETS VS SOLUTION IN HEALTHY-VOLUNTEERS, Journal of pharmaceutical sciences, 83(10), 1994, pp. 1421-1424
Risultati: 1-10 |